Xinteza API
Cannabinoid-based Active Pharmaceutical Ingredients
StartupXinteza API is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2019. Cannabinoid-based Active Pharmaceutical Ingredients. Xinteza API was founded by Alon Gal, Ron Klein, Zohar Koren. The company has 1-10 employees. Core technologies: Biologicals, Molecules, Genes.
The company follows a B2B business model. Product stage: R&D. The company holds 1 patent.
- StageSeed
- ProductR&D
- ModelB2B
- Employees1-10
- HQTel Aviv-Yafo
- DistrictCenter District
- Last RoundUndisclosed
Alon GalCo-founder & CEO
Ron KleinCo-Founder and COO & CFO
Zohar KorenCo-founder & CTO
3 articles covered by sources including www.prnewswire.com,
www.newswire.ca.
What does Xinteza API do?
Xinteza is developing advanced proprietary biosynthesis and bioextraction technologies related to the production of cannabinoid-based active pharmaceutical ingredients (APIs) for the pharmaceutical and food industries. The company is engaged in the research and discovery of a wide array of new genes and ultra-novel genetic paths for the biosynthesis of cannabinoids and psychoactive ingredients and the development of their bioproduction methods. Xinteza holds the exclusive license for both cannabinoids and psychoactives from the Weizmann Institute and is building an exceptional portfolio of dozens of related IP and patents.
Who founded Xinteza API?
Xinteza API was founded in 2019 by Alon Gal (Co-founder & CEO), Ron Klein (Co-Founder and COO & CFO), Zohar Koren (Co-founder & CTO).
What sector is Xinteza API in?
Xinteza API operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Medical Cannabis, with core technologies in Biologicals, Molecules, Genes. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is Xinteza API located?
Xinteza API is based in Tel Aviv, Israel, Center District.